DC, when fully matured are the APC best able to activate naïve T cells. Recently, we demonstrated using adenoviruses overexpressing IjBa and proteosome inhibitors that NF-jB is involved in DC activation, but the role of the individual subunits is still not clear. We investigated the role of the NF-jB subunits RelB and p50 in human DC activation using adenoviral vectors expressing RelB or p50. Nuclear RelB, in the form of RelB/p50, was active only in DC infected with both viruses, this induced the production of the soluble homeostatic chemokine CCL19, but not other homeostatic chemokines, particularly in LPS-matured DC. However, RelB/p50 did not affect the expression of costimulatory and antigen-presenting molecules, and increased the allogeneic mixed lymphocyte reaction only in LPS-matured DC. This enhanced mixed lymphocyte reaction is most likely due to enhanced CCL19 production, which sustains the interaction between mature DC and naïve T cells. In conclusion, we demonstrated that RelB/p50 was active only in DC expressing both RelB and p50, and induced CCL19 production, but not DC maturation.Key words: Chemokines . DC . Human . Transcription factors Supporting Information available online Introduction DC have an important role in the immune system, being the only APC able to activate naïve T cells. After antigen uptake, peripheral DC mature and migrate to the secondary lymphoid organs, where they prime T cells to become immune effector cells. DC, in their immature or semi-mature state, in contrast are tolerogenic and can induce T cells with suppressive properties [1,2] that would impair an immune response.The maturational stage of DC, together with the action of cytokines and immunosuppressive agents, is thus a critical factor in the function of these cells, determining whether they promote or inhibit immune responses. For this reason understanding the signals that control DC maturation [3] is important to elucidate how to regulate the immune response in order to benefit in various conditions, such as autoimmune diseases, transplantation, vaccination or anti-tumor therapy [4].In vitro, immature DC are driven to full maturation by ligands such as LPS or CD40L, while stimuli such as TNF-a or mixtures of pro-inflammatory cytokines bring DC to an intermediate activation stage [2].Chemokines closely regulate the migration and functionality of DC according to their maturational stage; immature DC are responsive to inflammatory chemokines, such as CXCL8 (IL-8), CXCL10 (IP-10), CCL3 (MIP-1a) or CCL20 , that recruit them from the bloodstream to the periphery where the antigen is present. Once they are activated, they start migrating to the lymphoid organs, attracted by homeostatic chemokines such as CCL19 (MIP-3b/ELC), CCL21 (6Ckine/SLC), CXCL13 (BLC/ BCA-1) and produce several chemokines that act specifically on T cells, B cells and activated DC [5,6]
2215The NF-kB family of transcription factors plays a key role in regulating inflammation, immunity and lymphoid organ development [7] and, in particular, is involved i...